oil control hair care base

1. INCI & CAS

INCI: Zinc PCA · CAS: 15454-75-8

2. Role in the formula

Zinc PCA (zinc pidolate) is a water-soluble zinc salt used in cosmetic oil-balance guides. It is not an antibacterial drug claim.

3. Typical use levels (formulation guide)

• The gels and scalp serums use-level reference is 0.3–1%.

Dissolve in water. Check compatibility with anionic thickeners.

4. Regulatory sources & global compliance

• A CosIng listing for Zinc PCA provides ingredient information, not approval of a supplied grade or finished product.
• EU cosmetics rules under Regulation (EC) No 1223/2009 require an assessment of the safety of the final cosmetic containing Zinc PCA for the product in its final form.
• Establish grade-specific details for Zinc PCA from the supplier and assess filing requirements in the intended market.

5. Safety & risk assessment

The guide records a level for cosmetic formulation purposes; the note establishes neither drug approval nor OTC-monograph status and the finished formula still needs patch and stability testing.

6. Stability & packaging

Store the bulk in a closed container in a cool, shaded place; choose a package with oxidation sensitivity in view; check the finished batch's stability and package compatibility.

7. Claims language (Do / Don’t)

• The listed cosmetic direction for Zinc PCA emphasizes zinc PCA balance.

• The cosmetic listing is not evidence of therapeutic outcomes, clinical cures, or a certification the finished SKU does not hold.
• The formulation record for Zinc PCA does not establish whitening effects, acne treatment, antiperspirant performance, sunscreen protection, or hair growth.

1. INCI & CAS

INCI: Niacinamide · CAS: 98-92-0

2. Role in the formula

Niacinamide is widely used in leave-on cosmetic guides around 2–5%. This is not a drug monograph claim and not a whitening drug claim.

3. Typical use levels (formulation guide)

• Serums may use the guide range 2–5% for the formula.
• Gel-creams: 2–4% in this reference.
• Toners: 2–3% for the formula.

Dissolve in the water phase. Keep finished pH roughly 5–6.5 so it stays in the cosmetic range used by formulators.

4. Regulatory sources & global compliance

• If Niacinamide appears in CosIng, its entry is informational and does not approve a specific grade or finished cosmetic.
• Regulation (EC) No 1223/2009 sets the requirement for a product-level safety assessment for the complete formula that contains Niacinamide before the cosmetic is placed on the EU market.
• Verify the purchased Niacinamide grade using supplier data, alongside the applicable filing rules for the destination market.

5. Safety & risk assessment

This entry provides guidance for cosmetic use only; it does not authorize a drug or OTC product so patch response and stability should be checked on the finished product.

6. Stability & packaging

Hold the bulk material in a sealed, cool place shielded from light; where oxidation is a concern, evaluate airless or pump packaging; use batch testing to verify stability and package compatibility.

7. Claims language (Do / Don’t)

• For cosmetic use, this entry records Niacinamide in a direction centered on niacinamide conditioning.

• The cosmetic listing does not substantiate claims of drug activity, a clinical cure, or an undocumented product certification.
• The Niacinamide entry cannot verify whitening, treatment of acne, perspiration control, sun protection, or hair growth.

1. INCI & CAS

INCI: Caprylic/Capric Triglyceride · CAS: 73398-61-5

2. Role in the formula

For light-oil use in lotions, balms, and cleansing oils, the reference lists caprylic/capric triglyceride.

3. Typical use levels (formulation guide)

• Formulation guidance for lotions: 3–8% for the formula.
• The stated reference for cleansing oils and balms is 20–60%.

The guide places Caprylic/Capric Triglyceride in the oil phase.

4. Regulatory sources & global compliance

• The CosIng record for Caprylic/Capric Triglyceride, where listed, is informational rather than product-specific authorization.
• EU market placement under Regulation (EC) No 1223/2009 requires a safety evaluation of the product containing Caprylic/Capric Triglyceride as it will be marketed for the completed formula, not simply for an ingredient in isolation.
• Review the supplier TDS for the received Caprylic/Capric Triglyceride grade, together with the target market's current filing requirements.

5. Safety & risk assessment

The percentage is shown for cosmetic development; it does not establish drug approval or OTC-monograph status and the final formula should undergo patch and stability assessment.

6. Stability & packaging

Keep bulk material sealed, cool, and out of direct sunlight; review airless or pump options if oxidation presents a concern; check the finished batch's stability and package compatibility.

7. Claims language (Do / Don’t)

• The formulation note describes Caprylic/Capric Triglyceride as part of a cosmetic direction focused on light-triglyceride.

• This product entry does not establish drug claims, cure claims, or a certification that is absent from the product records.
• The information about Caprylic/Capric Triglyceride does not support whitening, treatment of acne, perspiration control, sun protection, or hair growth.